AAAAAA

   
Results: 1-13 |
Results: 13

Authors: Altemus, M Dale, JK Michelson, D Demitrack, MA Gold, PW Straus, SE
Citation: M. Altemus et al., Abnormalities in response to vasopressin infusion in chronic fatigue syndrome, PSYCHONEURO, 26(2), 2001, pp. 175-188

Authors: Michelson, D Schmidt, M Lee, J Tepner, R
Citation: D. Michelson et al., Changes in sexual function during acute and six-month fluoxetine therapy: A prospective assessment, J SEX MAR T, 27(3), 2001, pp. 289-302

Authors: Michelson, D Faries, D Wernicke, J Kelsey, D Kendrick, K Sallee, FR Spencer, T
Citation: D. Michelson et al., Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled, dose-response study, PEDIATRICS, 108(5), 2001, pp. NIL_33-NIL_41

Authors: Michelson, D
Citation: D. Michelson, Female sexual dysfunction and antidepressant use - Dr. Michelson replies, AM J PSYCHI, 158(2), 2001, pp. 327-327

Authors: Michelson, D Amsterdam, J Apter, J Fava, M Londborg, P Tamura, R Pagh, L
Citation: D. Michelson et al., Hormonal markers of stress response following interruption of selective serotonin reuptake inhibitor treatment, PSYCHONEURO, 25(2), 2000, pp. 169-177

Authors: Michelson, D Fava, M Amsterdam, J Apter, J Londborg, P Tamura, R Tepner, RG
Citation: D. Michelson et al., Interruption of selective serotonin reuptake inhibitor treatment - Double-blind, placebo-controlled trial, BR J PSYCHI, 176, 2000, pp. 363-368

Authors: Henry, ME Moore, CM Kaufman, MJ Michelson, D Schmidt, ME Stoddard, E Vuckevic, AJ Berreira, PJ Cohen, BM Renshaw, PF
Citation: Me. Henry et al., Brain kinetics of paroxetine and fluoxetine on the third day of placebo substitution: A fluorine MRS study, AM J PSYCHI, 157(9), 2000, pp. 1506-1508

Authors: Michelson, D Bancroft, J Targum, S Kim, Y Tepner, R
Citation: D. Michelson et al., Female sexual dysfunction associated with antidepressant administration: Arandomized, placebo-controlled study of pharmacologic intervention, AM J PSYCHI, 157(2), 2000, pp. 239-243

Authors: Zajecka, J Amsterdam, JD Quitkin, FM Reimherr, FW Rosenbaum, JF Tamura, RN Sundell, KL Michelson, D Beasley, CM
Citation: J. Zajecka et al., Changes in adverse events reported by patients during 6 months of fluoxetine therapy, J CLIN PSY, 60(6), 1999, pp. 389-394

Authors: Michelson, D
Citation: D. Michelson, Comparing the efficacy and safety of fluoxetine and venlafaxine in outpatient depression, J CLIN PSY, 60(5), 1999, pp. 338-339

Authors: Michelson, D Pollack, M Lydiard, RB Tamura, R Tepner, R Tollefson, G
Citation: D. Michelson et al., Continuing treatment of panic disorder after acute response: randomised, placebo-controlled trial with fluoxetine, BR J PSYCHI, 174, 1999, pp. 213-218

Authors: Michelson, D Amsterdam, JD Quitkin, FM Reimherr, FW Rosenbaum, JF Zajecka, J Sundell, KL Kim, Y Beasley, CM
Citation: D. Michelson et al., Changes in weight during a 1-year trial of fluoxetine, AM J PSYCHI, 156(8), 1999, pp. 1170-1176

Authors: Michelson, D Lydiard, B Pollack, MH Tamura, RN Hoog, SL Tepner, R Demitrack, MA Tollefson, GD
Citation: D. Michelson et al., Outcome assessment and clinical improvement in panic disorder: Evidence from a randomized controlled trial of fluoxetine and placebo (vol 155, pg 1570, 1998), AM J PSYCHI, 156(1), 1999, pp. 161-161
Risultati: 1-13 |